Parmax Pharma Ltd

Parmax Pharma Ltd

₹ 38.0 0.00%
17 Jun 10:25 a.m.
About

Incorporated in 1994, Parmax Pharma Ltd manufactures bulk drugs, drugs intermediates, and specialty chemicals[1]

Key Points

Business Overview:[1]
Company used to do manufacturing bulk drugs and specialty chemicals but it discontinued its business activities for a few years. It deals in active pharmaceutical ingredients and Contract Manufacturing Operations. It plans to extend its activity to the formulation of Tablets, Ointments,
Capsules, and Injectables.

  • Market Cap 14.2 Cr.
  • Current Price 38.0
  • High / Low 55.0 / 28.7
  • Stock P/E
  • Book Value -5.32
  • Dividend Yield 0.00 %
  • ROCE -12.5 %
  • ROE %
  • Face Value 10.0

Pros

  • Debtor days have improved from 30.5 to 16.6 days.

Cons

  • Company has low interest coverage ratio.
  • Promoter holding is low: 30.8%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
1.56 2.13 5.35 6.38 1.40 4.07 1.33 4.26 7.82 9.28 6.28 4.83
2.34 2.26 3.03 5.54 2.05 4.84 2.48 5.06 7.31 9.08 6.17 5.39
Operating Profit -0.78 -0.13 2.32 0.84 -0.65 -0.77 -1.15 -0.80 0.51 0.20 0.11 -0.56
OPM % -50.00% -6.10% 43.36% 13.17% -46.43% -18.92% -86.47% -18.78% 6.52% 2.16% 1.75% -11.59%
0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.12 0.01 -1.17
Interest 0.09 0.12 0.11 0.05 0.12 0.18 0.16 0.16 0.11 0.13 0.11 0.24
Depreciation 0.46 0.47 0.48 0.47 0.42 0.43 0.45 0.41 0.40 0.40 0.41 -0.18
Profit before tax -1.32 -0.71 1.74 0.33 -1.18 -1.37 -1.75 -1.36 0.01 -0.21 -0.40 -1.79
Tax % 0.00% 0.00% 0.00% 48.48% 0.00% 0.00% 0.00% 6.62% 0.00% 0.00% 0.00% -16.76%
-1.32 -0.70 1.74 0.17 -1.18 -1.37 -1.75 -1.45 0.01 -0.22 -0.39 -1.49
EPS in Rs -3.53 -1.87 4.65 0.45 -3.15 -3.66 -4.68 -3.88 0.03 -0.59 -1.04 -3.98
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0.00 0.00 0.00 0.00 11.89 11.99 20.92 26.17 18.24 15.39 11.02 28.20
0.02 0.02 0.05 0.05 10.81 10.88 19.15 22.74 15.67 13.14 14.39 27.94
Operating Profit -0.02 -0.02 -0.05 -0.05 1.08 1.11 1.77 3.43 2.57 2.25 -3.37 0.26
OPM % 9.08% 9.26% 8.46% 13.11% 14.09% 14.62% -30.58% 0.92%
0.06 0.06 0.06 0.06 0.05 0.05 0.10 0.09 0.06 0.04 0.05 -1.03
Interest 0.00 0.00 0.00 0.00 0.04 0.03 0.13 0.37 0.39 0.37 0.62 0.59
Depreciation 0.00 0.00 0.00 0.00 1.09 1.03 1.01 1.94 1.93 1.88 1.71 1.03
Profit before tax 0.04 0.04 0.01 0.01 0.00 0.10 0.73 1.21 0.31 0.04 -5.65 -2.39
Tax % 0.00% 25.00% 200.00% 100.00% 20.00% 41.10% 38.02% 54.84% 375.00% 2.12% -12.55%
0.04 0.02 0.00 -0.01 0.00 0.08 0.43 0.75 0.14 -0.10 -5.78 -2.09
EPS in Rs 0.10 0.05 0.00 -0.03 0.00 0.21 1.15 2.00 0.37 -0.27 -15.45 -5.59
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: 6%
3 Years: 16%
TTM: 156%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 82%
Stock Price CAGR
10 Years: %
5 Years: 2%
3 Years: 4%
1 Year: 27%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 3.90 4.03 4.45 4.45 4.45 4.45 4.45 4.45 4.45 4.45 4.45 4.45
Reserves 0.09 0.12 0.11 0.10 0.11 0.18 0.61 1.37 1.51 1.40 -4.38 -6.44
0.92 0.79 0.46 1.02 1.96 5.52 5.26 5.89 5.18 5.37 5.91 7.70
0.09 0.04 0.06 2.14 10.11 9.56 10.75 11.01 6.83 6.39 9.35 13.04
Total Liabilities 5.00 4.98 5.08 7.71 16.63 19.71 21.07 22.72 17.97 17.61 15.33 18.75
2.53 2.53 2.53 2.72 5.86 4.92 9.64 10.84 10.44 9.50 9.27 7.97
CWIP 0.00 0.00 0.00 0.00 0.00 3.33 0.00 0.00 0.00 0.00 0.10 0.00
Investments 0.00 0.00 0.00 0.00 0.00 0.20 0.20 0.20 0.00 0.00 0.00 0.40
2.47 2.45 2.55 4.99 10.77 11.26 11.23 11.68 7.53 8.11 5.96 10.38
Total Assets 5.00 4.98 5.08 7.71 16.63 19.71 21.07 22.72 17.97 17.61 15.33 18.75

Cash Flows

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-0.01 -0.06 0.00 -0.50 3.88 0.92 2.82 3.53 0.75 0.33 -0.19 -0.66
0.00 0.00 0.00 -0.19 -4.23 -3.41 -2.40 -3.15 -1.53 -0.94 -1.59 -0.70
0.01 0.00 0.10 0.56 1.14 3.10 -0.23 0.40 -0.91 -0.04 1.43 1.40
Net Cash Flow 0.00 -0.06 0.09 -0.14 0.79 0.61 0.20 0.78 -1.69 -0.65 -0.35 0.04

Ratios

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 60.48 35.01 57.58 23.01 13.61 14.70 60.28 16.57
Inventory Days 203.34 278.66 88.17 107.27 154.80 286.55 123.74 56.09
Days Payable 609.39 645.07 311.84 269.40 299.82 309.82 382.60 173.18
Cash Conversion Cycle -345.57 -331.40 -166.09 -139.12 -131.41 -8.57 -198.58 -100.52
Working Capital Days -59.86 -71.84 -56.18 -48.26 -36.02 -0.47 -115.59 -40.51
ROCE % 0.82% 0.81% 0.20% 0.19% 0.66% 1.56% 8.40% 14.34% 6.13% 3.67% -58.49% -12.49%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
30.80% 30.80% 30.80% 30.80% 30.80% 30.80% 30.80% 30.83% 30.80% 30.80% 30.80% 30.80%
69.20% 69.19% 69.19% 69.19% 69.20% 69.19% 69.19% 69.16% 69.19% 69.20% 69.20% 69.20%
No. of Shareholders 1,5901,01,6502,0351,9971,9781,9732,0022,0992,1852,2462,3342,356

Documents